These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25624117)

  • 1. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.
    Macha MA; Krishn SR; Jahan R; Banerjee K; Batra SK; Jain M
    Cancer Treat Rev; 2015 Mar; 41(3):277-88. PubMed ID: 25624117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
    Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
    Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases.
    Andrianifahanana M; Moniaux N; Batra SK
    Biochim Biophys Acta; 2006 Apr; 1765(2):189-222. PubMed ID: 16487661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of mucins: unexplored conundrum.
    Kumar S; Cruz E; Joshi S; Patel A; Jahan R; Batra SK; Jain M
    Carcinogenesis; 2017 Jul; 38(7):671-679. PubMed ID: 27838635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucins and toll-like receptors: kith and kin in infection and cancer.
    Tarang S; Kumar S; Batra SK
    Cancer Lett; 2012 Aug; 321(2):110-9. PubMed ID: 22306702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes.
    Kilcoyne M; Gerlach JQ; Gough R; Gallagher ME; Kane M; Carrington SD; Joshi L
    Anal Chem; 2012 Apr; 84(7):3330-8. PubMed ID: 22390135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered mucin mouse models for inflammation and cancer.
    Joshi S; Kumar S; Bafna S; Rachagani S; Wagner KU; Jain M; Batra SK
    Cancer Metastasis Rev; 2015 Dec; 34(4):593-609. PubMed ID: 25634251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy.
    Cerella C; Sobolewski C; Dicato M; Diederich M
    Biochem Pharmacol; 2010 Dec; 80(12):1801-15. PubMed ID: 20615394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface mucins and local inflammation--studies in genetically modified mouse lines.
    Shirai K; Saika S
    BMC Ophthalmol; 2015 Dec; 15 Suppl 1(Suppl 1):154. PubMed ID: 26818460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucins as multifunctional building blocks of biomaterials.
    Petrou G; Crouzier T
    Biomater Sci; 2018 Aug; 6(9):2282-2297. PubMed ID: 30047553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.
    Dhanisha SS; Guruvayoorappan C; Drishya S; Abeesh P
    Crit Rev Oncol Hematol; 2018 Feb; 122():98-122. PubMed ID: 29458795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-target approach for natural products in inflammation.
    Koeberle A; Werz O
    Drug Discov Today; 2014 Dec; 19(12):1871-82. PubMed ID: 25172801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of thioether-linked analogues of the 2,3-sialyl-TF and MECA-79 antigens: mucin-type glycopeptides associated with cancer and inflammation.
    Marcaurelle LA; Pratt MR; Bertozzi CR
    Chembiochem; 2003 Mar; 4(2-3):224-8. PubMed ID: 12616638
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
    Singh AP; Chaturvedi P; Batra SK
    Cancer Res; 2007 Jan; 67(2):433-6. PubMed ID: 17234748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory tract mucin genes and mucin glycoproteins in health and disease.
    Rose MC; Voynow JA
    Physiol Rev; 2006 Jan; 86(1):245-78. PubMed ID: 16371599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications.
    Lakshmanan I; Ponnusamy MP; Macha MA; Haridas D; Majhi PD; Kaur S; Jain M; Batra SK; Ganti AK
    J Thorac Oncol; 2015 Jan; 10(1):19-27. PubMed ID: 25319180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?
    Barrera MJ; Aguilera S; Veerman E; Quest AF; Díaz-Jiménez D; Urzúa U; Cortés J; González S; Castro I; Molina C; Bahamondes V; Leyton C; Hermoso MA; González MJ
    Rheumatology (Oxford); 2015 Aug; 54(8):1518-27. PubMed ID: 25802401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.
    Jonckheere N; Van Seuningen I
    Biochimie; 2010 Jan; 92(1):1-11. PubMed ID: 19818375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways: Mucins and Drug Delivery in Cancer.
    Rao CV; Janakiram NB; Mohammed A
    Clin Cancer Res; 2017 Mar; 23(6):1373-1378. PubMed ID: 28039261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
    Taylor-Papadimitriou J; Epenetos AA
    Trends Biotechnol; 1994 Jun; 12(6):227-33. PubMed ID: 7765069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.